Abbvie pays up to €895m for Irish funded dementia drug group
Belgian company Syndesi Therapeutics was backed by Irish VC Fountain Healthcare on spin-out
German study confirms efficacy of Irish tinnitus therapy
Neuromod welcomes independent real-world study confirming clinical trial data
Fountain Healthcare Partners invests in Dutch biotech Calypso
Company completes dosing in first round of trial of treatment for coeliac disease
Back pain device group Mainstay Medical raises $108m
Funding will drive commercialisation of Reactiv8 in critical US market
Trust the Irish to cure a runny nose
Galway-based Neurent looks to capitalise on treatment for one of the most common chronic conditions
Neurent Medical raises €20.6m to commercialise runny nose cure
Galway medical device group sees $2bn market for novel rhinitis device
Fountain closes third life sciences fund after raising €125m
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Neuromod tinnitus trial shows significant results for Lenire
Large-scale trial shows improvement after 12 weeks, sustained results after 12 months
Year to remember for Fountain Healthcare Partners
Cantillon: Venture capital business sells Inflazome to Roche for €380m
Swiss drug giant Roche pays €380m for Irish biotech Inflazome
Company developing medicines for chronic inflammatory diseases such as Alzheimer’s
Bayer buys developer of treatment for menopausal symptoms
Acquisition of KaNDy Therapeutics a win for Irish VC investor Fountain Healthcare
Septic shock study gets €5m funding from Irish life sciences VC
Fountain Healthcare invests in French start-up Inotrem which targets condition with 35% mortality rate
Looking for finance? Don’t always bank on it
Bank debt isn’t the only game in town for businesses. Here are some alternatives
Medtech firm Neuromod Devices raises €8m in capital
Company plans to ramp up commercialisation of tinnitus treatment
Irish VC group Fountain Healthcare Partners raises €118m
Group beats €100m target and intends to invest the bulk of the fund in Europe and US
Irish merger and acquisitions up, along with value of deals
Figures from Mergermarket show the value of transactions jumped 370% in 2018
Paschal meets Apple bigwigs as AIB seeks help-to-buy scheme extension
Seen and heard: PwC to review children’s hospital costs, ESB may offload Dublin depot
Irish biotech Inflazome in €40m fundraising
Inflazome in one of the largest European biotech fundraisings this year as it targets range of serious inflammatory diseases
Amarin – an overnight success 10 years in the making
After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market
Kandy Therapeutics raises £25m for menopause drug
Irish healthcare venture capital group Fountain among backers of HRT alternative
Mainstay Medical hits milestone in key US clinical trial
Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device
Neurent raises €9.3m to put paid to chronic runny noses
Galway medical device firm developing rhinitis cure device for use in doctors’ offices
Irish company to showcase ‘breakthrough’ breast cancer drug
Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer
Irish VC backs Belgian start-up investigating dementia therapy
Fountain Healthcare participates in €17m funding round for Syndesi Therapeutics
Neuromod hires research expert in move to bring tinnitus device to market
Irish medtech start-up seeking to commercialise non-invasive device for condition
Mainstay Medical to seek further funding as full-year losses mount
Dublin-listed medical devices firm recently made its first commercial sale in Germany
Johnson & Johnson buys Irish stroke care firm in multimillion euro deal
Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009
Mainstay Medical sells its first ReActiv8 implant for back pain
Iseq-listed medical device firm targets commercial growth and completion of US clinical trials
Mainstay Medical seeks approval to sell ReActiv8 in Australia
Dublin-listed firm pushes ahead with plans to commercialise back pain treatment
Mainstay Medical adds eighth US patent to its IP portfolio
Company’s flagship product ReActiv8 won European approval earlier this year
Fountain Healthcare invests in $47.6m stop smoking device
Chrono Therapeutics developing device to deliver nicotine through skin in timed doses
Galway med tech firm Vivasure raises €16.5m in funding
Start-up’s technology allows surgeons to finish heart surgery without leaving stitches
Irish-headquartered Mainstay sees losses narrow to $13m
Operating expenses also decline while R&D and clinical and regulatory costs rise
Innocoll prices shares at $7 for $40m public offering
Firm developing products to treat postoperative pain and diabetic foot infections
Mainstay Medical raises €30m to bring back pain device to market
Irish company has won European approval of neurostimulator to treat chronic lower back pain and targeting US market
Dublin gene therapy company bought in deal worth €15m
US biopharma group Spark Therapeutics buys Dublin-based Trinity spin-out Genable Technologies
Mainstay Medical to seek European approval for device
A trial of 47 patients showed after three months, 63 per cent reported clinically important improvement in back pain
Elan gene pool continues to deliver
Elan executives turn their sights to funding side of biotech/life sciences business
Irish life sciences fund Fountain raises €85m in second fund
Group targeting European investments in specialty pharma, biotech, medical devices and diagnostics
Irish VC Fountain wins in $525m Parkinson’s drug deal
Alkermes spinoff also delivers dividend for drug technology group
Mainstay Medical raises €18m in €90m floatation in Paris and Dublin
Proceeds will fund clinical trials of back pain device as shares float at lower end of guided range
Medical device group Mainstay plans €100m flotation
Irish back pain group hopes to raise €20m to fund clinical trials and other costs of bringing device to market
Back pain group plans stock market float
Mainstay Medical looking to list in Paris and Dublin as it trials first product
Dublin tech company to work with US biopharma group
Genable Technologies will licence certain intellectual property from Spark under deal
Mainstay starts clinical trials on back pain therapy
Implanted Reactiv8 unit designed to stabilise spinal muscles with electrical impulses
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices